In recent years, domestic medicine cartoning machines have experienced rapid growth, but the level of manufacturing R&D is still not comparable to international advanced technologies, especially high-end products. With the reform of China's medical system, the prosperity of the pharmaceutical market, and the increase in the output of medicines, the development of the medicine cartoning machine in China will surely usher in a leap-forward development.
In the past ten years, although China's domestic medicine cartoning machines have achieved rapid development, the problems they face are still amongst the manufacturers of automatic cartoning machines in the domestic pharmaceutical equipment industry. The technical content and quality are relatively high. There are few high manufacturers, and most of them stay at semi-auto or mid-low speed levels.
It is understood that at present, the market share of domestic medicine cartoning machines is only 30%, and the rest of the markets are divided by imported products. At present, many of the larger pharmaceutical manufacturers in China still use imported cartoning machines.
Foreign similar products, regardless of the level of development in the level of equipment and application of technology content is not satisfactory in the market distribution, domestic drug loading machine only slightly advantage in the middle and low market, while the high-end market is almost all foreign products Occupy.
The domestic cartoning machine wants to catch up with the international pace, and the automatic cartoning machine will be an important customs weapon. The automatic cartoning machine has the advantages of simple operation and powerful functions, and can complete a variety of more complex drug loading work, greatly improving the degree of automation of the pharmaceutical packaging industry. As China's pharmaceutical automatic cartoning machine industry market is far from being met, different packaging requirements are constantly put forward. It also requires the cartoning machine industry to follow the trend, change with time, accelerate innovation, and better meet market demands.
Nowadays, with the increasing size of the pharmaceutical market in China, the ever-increasing variety of products, the continuous increase in the number of drug manufacturers, and the continuous improvement in the degree of automation in production, it is believed that the development and production of domestic medicine cartoning machines will have major breakthroughs in the near future.
In the past ten years, although China's domestic medicine cartoning machines have achieved rapid development, the problems they face are still amongst the manufacturers of automatic cartoning machines in the domestic pharmaceutical equipment industry. The technical content and quality are relatively high. There are few high manufacturers, and most of them stay at semi-auto or mid-low speed levels.
It is understood that at present, the market share of domestic medicine cartoning machines is only 30%, and the rest of the markets are divided by imported products. At present, many of the larger pharmaceutical manufacturers in China still use imported cartoning machines.
Foreign similar products, regardless of the level of development in the level of equipment and application of technology content is not satisfactory in the market distribution, domestic drug loading machine only slightly advantage in the middle and low market, while the high-end market is almost all foreign products Occupy.
The domestic cartoning machine wants to catch up with the international pace, and the automatic cartoning machine will be an important customs weapon. The automatic cartoning machine has the advantages of simple operation and powerful functions, and can complete a variety of more complex drug loading work, greatly improving the degree of automation of the pharmaceutical packaging industry. As China's pharmaceutical automatic cartoning machine industry market is far from being met, different packaging requirements are constantly put forward. It also requires the cartoning machine industry to follow the trend, change with time, accelerate innovation, and better meet market demands.
Nowadays, with the increasing size of the pharmaceutical market in China, the ever-increasing variety of products, the continuous increase in the number of drug manufacturers, and the continuous improvement in the degree of automation in production, it is believed that the development and production of domestic medicine cartoning machines will have major breakthroughs in the near future.
Epoxy Curing Agents & Accelerators
Kylin Chemicals has been focusing on R&D, manufacturing and supply of specialty additive technologies to epoxy resin industry for over 20 years. Our novel technologies are marketed & supplied under the trade name KylinCure, serving our customers in the field of composites, coatings, adhesives and electric industries, etc. KylinCure is a group of substituted urea based accelerator for dicyandiamide-cured epoxy resins, significantly reduces the curing temperature without sacrificing the shelf life of the compounds.
Epoxy Curing Agents & Accelerators,Curing Agents For Epoxy Resin,Epoxy Curing Accelerating Agent
Kylin Chemicals Co., Ltd. , https://www.kylin-chemicals.com